First FDA-approved Gene Therapy

General
1

The US FDA has approved Lyfgenia, also known as lovotibeglogene autotemcel, which has shown positive results in treating sickle cell anemia.

How Lyfgenia Works:

Gene Modification: Lyfgenia uses a patient’s own blood stem cells, which are genetically modified to produce functional hemoglobin.

Infusion:The modified stem cells are infused back into the patient’s body, where they produce healthy red blood cells.

5 Likes
2

Informative.

1 Like
3

Informative :+1:

1 Like
4

Informative . Thanks for sharing.

1 Like
5

What is the current price and how beneficial is it?

1 Like
6

Woah studied that in my previous sem great to see this is actually working right

1 Like
7

I’m unaware of the therapy’s aftermath and pricing. I’ll update you if I find out anything new about this. :slightly_smiling_face:

8

Informative piece

1 Like
9

Insightful!